Moderna Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Moderna, Inc. (MRNA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-3.56-4.718.3612.20-0.75-0.51-0.38
Depreciation & Amortization0.190.620.350.230.030.030.02
Deferred Income Tax0.000.83-0.56-0.320.000.000.00
Stock Based Compensation0.430.310.230.140.090.000.00
Change in Working Capital-0.080.69-4.011.312.58-0.06-0.04
Change in Accounts Receivable0.530.491.79-1.78-1.390.000.00
Change in Inventory0.080.750.49-1.39-0.050.000.00
Change in Accounts Payable-0.070.010.240.200.010.000.00
Change in Other Working Capital-0.191.500.030.580.160.000.00
Other Operating Activities0.060.010.03-0.320.160.090.00
Net Cash from Operating Activities-3.00-3.124.9813.622.03-0.46-0.33
Investing Activities
Capital Expenditures-1.05-0.71-0.40-0.280.070.03-0.11
Acquisitions0.00-0.090.000.000.000.000.00
Purchases of Investments3.005.02-11.44-8.21-1.600.000.00
Sales/Maturities of Investments9.538.786.704.44-1.600.02-0.27
Other Investing Activities0.00-0.02-0.04-0.030.000.000.00
Net Cash from Investing Activities1.954.21-5.18-8.52-1.67-0.01-0.37
Financing Activities
Debt Repayment-0.010.000.00-0.140.010.000.00
Common Stock Issued0.070.050.070.122.040.051.22
Common Stock Repurchased0.00-1.15-3.33-0.860.000.000.00
Other Financing Activities0.000.00-0.18-0.14-0.010.000.00
Net Cash from Financing Activities0.06-1.38-3.45-0.872.030.051.23
Summary
Net Change in Cash-1.00-0.29-3.644.222.39-0.420.52
Cash at Beginning of Period2.933.226.862.640.250.670.15
Cash at End of Period1.932.933.226.862.640.250.67
Free Cash Flow-4.06-3.834.5813.341.96-0.49-0.44
Supplemental Disclosures
Interest Paid0.020.040.030.010.010.010.00
Income Taxes Paid0.20-0.362.730.480.000.000.00